Quest Diagnostics Incorporated (0KSX.L)
LSE - LSE Delayed price. Currency in USD
Add to watchlist
At close: 04:51PM BST
| Previous close | 138.39 |
| Open | 137.73 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 137.67 - 138.05 |
| 52-week range | 119.84 - 147.55 |
| Volume | |
| Avg. volume | 1,609 |
| Market cap | 18.701B |
| Beta (5Y monthly) | 0.89 |
| PE ratio (TTM) | 0.09 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Is It Apt to Hold Quest Diagnostics (DGX) Stock for Now?
Strength in the core business bodes well for Quest Diagnostics (DGX). However, mounting debt levels and reduced COVID-19 testing revenues pose concerns.
- Zacks
Quest Diagnostics (DGX) Gains From New M&As Amid Competition
In Physician Lab Services, Quest Diagnostics (DGX) is benefiting from the broad-based return to care, overall market growth and share gains driven by the competitive strength of its scale and innovative offerings.
- Zacks
Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis
Quest Diagnostics (DGX) completes the acquisition of PathAI Diagnostics, accelerating the adoption of AI and digital pathology to improve cancer diagnosis.
© 2024 Yahoo. All rights reserved.